Association of a syndrome resembling Wegener's granulomatosis with low surface expression of HLA class-I molecules

被引:99
作者
Moins-Teisserenc, HT
Gadola, SD
Cella, M
Dunbar, PR
Exley, A
Blake, N
Baykal, C
Lambert, J
Bigliardi, P
Willemsen, M
Jones, M
Buechner, S
Colonna, M
Gross, WL
Cerundolo, V [1 ]
机构
[1] Inst Mol Med, Nuffield Dept Med, Oxford OX3 9DS, England
[2] Univ Lubeck, Rheumaklin Bad Bramstedt, D-2400 Lubeck, Germany
[3] Basel Inst Immunol, Basel, Switzerland
[4] CRC, Inst Canc Studies, Birmingham, W Midlands, England
[5] Istanbul Fac Med, Dept Dermatol, Istanbul, Turkey
[6] Univ Basel, Dept Dermatol, CH-4003 Basel, Switzerland
[7] Univ Birmingham, Dept Immunol, Birmingham B15 2TT, W Midlands, England
[8] Div Cellular Sci, Oxford, England
[9] Univ Ziekenhuis Antwerpen, Dept Dermatol, Edegem, Belgium
[10] Dept Dermatol, Brussels, Belgium
[11] Hop St Louis, INSERM, U0396, F-75010 Paris, France
基金
英国医学研究理事会;
关键词
D O I
10.1016/S0140-6736(99)04206-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Granulomatous syndromes, such as Wegener's granulomatosis, are defined according to complex criteria, but the underlying cause is rarely identified. We present evidence for a new aetiology for chronic granulomatous lesions associated with a recessive genetic defect, which is linked to the human leucocyte antigen (HLA) locus. Methods Five adults with necrotising granulomatous lesions in the upper respiratory tract and skin, associated with recurrent bacterial respiratory infections and skin vasculitis, were identified. A diagnosis of Wegener's granulomatosis was considered in all of them, but abandoned because of an incompatible disease course and resistance to immunosuppressive treatments. Peripheral-blood samples were taken and analysed by immunohistochemistry and fluorescent-activated-cell-sorter analysis. Since all five patients were homozygous for the HLA locus, we looked for genetic defects located within the HLA-locus with PCR and restriction fragment length polymorphism. Findings A severe decrease in cell-surface expression of HLA class-I molecule was seen in all patients. Defective expression of the transporter associated with antigen presentation (TAP) genes was responsible for the HLA class-I down-regulation, and in two patients we identified a mutation in the TAP2 gene responsible for the defective expression of the TAP complex. We showed the presence of autoreactive natural killer (NK) cells and gamma delta T lymphocytes in the peripheral blood cells of two patients. Correction of the genetic defect in vitro restored normal expression of HLA class-I molecules and prevented self-reactivity in the patients' cells. Histology of granulomatous lesions showed the presence of a large proportion of activated NK cells. Interpretation Our findings define the cause and pathogenesis of a new syndrome that affects patients with a defective surface expression of HLA class-I molecules. The syndrome resembles Wegener's granulomatosis both clinically and histologically. Patients have chronic necrotising granulomatous lesions in the upper respiratory tract and skin, recurrent infections of the respiratory tract, and skin vasculitis. A predominant NK population within the granulomatous lesions suggests that the pathophysiology of the skin lesions may relate to the inability of HLA class-I molecules to turn off NK cell responses. Accurate genetic analysis of a defined syndrome can provide a better understanding of the cause and pathogenesis of a disease.
引用
收藏
页码:1598 / 1603
页数:6
相关论文
共 22 条
  • [1] NK3-SPECIFIC NATURAL-KILLER-CELLS ARE SELECTIVELY INHIBITED BY BW4-POSITIVE HLA ALLELES WITH ISOLEUCINE-80
    CELLA, M
    LONGO, A
    FERRARA, GB
    STROMINGER, JL
    COLONNA, M
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) : 1235 - 1242
  • [2] Specificity and function of immunoglobulin superfamily NK cell inhibitory and stimulatory receptors
    Colonna, M
    [J]. IMMUNOLOGICAL REVIEWS, 1997, 155 : 127 - 133
  • [3] HLA class I deficiencies due to mutations in subunit 1 of the peptide transporter TAP1
    de la Salle, H
    Zimmer, J
    Fricker, D
    Angenieux, C
    Cazenave, JP
    Okubo, H
    Maeda, H
    Plebani, A
    Tongio, MM
    Dormoy, A
    Hanau, D
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (05) : R9 - R13
  • [4] HOMOZYGOUS HUMAN TAP PEPTIDE TRANSPORTER MUTATION IN HLA CLASS-I DEFICIENCY
    DELASALLE, H
    HANAU, D
    FRICKER, D
    URLACHER, A
    KELLY, A
    SALAMERO, J
    POWIS, SH
    DONATO, L
    BAUSINGER, H
    LAFORET, M
    JERAS, M
    SPEHNER, D
    BIEBER, T
    FALKENRODT, A
    CAZENAVE, JP
    TROWSDALE, J
    TONGIO, MM
    [J]. SCIENCE, 1994, 265 (5169) : 237 - 241
  • [5] WEGENERS GRANULOMATOSIS - PROSPECTIVE CLINICAL AND THERAPEUTIC EXPERIENCE WITH 85 PATIENTS FOR 21 YEARS
    FAUCI, AS
    HAYNES, BF
    KATZ, P
    WOLFF, SM
    [J]. ANNALS OF INTERNAL MEDICINE, 1983, 98 (01) : 76 - 85
  • [6] Splice acceptor site mutation of the transporter associated with antigen processing-1 gene in human bare lymphocyte syndrome
    Furukawa, H
    Murata, S
    Yabe, T
    Shimbara, N
    Keicho, N
    Kashiwase, K
    Watanabe, K
    Ishikawa, Y
    Akaza, T
    Tadokoro, K
    Tohma, S
    Inoue, T
    Tokunaga, K
    Yamamoto, K
    Tanaka, K
    Juji, T
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (05) : 755 - 758
  • [7] Tolerance of NK and LAK activity for HLA class I deficient targets in a TAP1-deficient patient (bare lymphocyte syndrome type I)
    Furukawa, H
    Yabe, T
    Watanabe, K
    Miyamoto, R
    Miki, A
    Akaza, T
    Tadokoro, K
    Tohma, S
    Inoue, T
    Yamamoto, K
    Juji, T
    [J]. HUMAN IMMUNOLOGY, 1999, 60 (01) : 32 - 40
  • [8] GROSS WL, 1998, OXFORD TXB RHEUMATOL, V2, P1331
  • [9] NOMENCLATURE OF SYSTEMIC VASCULITIDES - PROPOSAL OF AN INTERNATIONAL CONSENSUS CONFERENCE
    JENNETTE, JC
    FALK, RJ
    ANDRASSY, K
    BACON, PA
    CHURG, J
    GROSS, WL
    HAGEN, EC
    HOFFMAN, GS
    HUNDER, GG
    KALLENBERG, CGM
    MCCLUSKEY, RT
    SINICO, RA
    REES, AJ
    VANES, LA
    WALDHERR, R
    WIIK, A
    [J]. ARTHRITIS AND RHEUMATISM, 1994, 37 (02): : 187 - 192
  • [10] Inhibitory MHC class I receptors on NK cells and T cells
    Lanier, LL
    Phillips, JH
    [J]. IMMUNOLOGY TODAY, 1996, 17 (02): : 86 - 91